Ann: Date of Annual General Meeting, page-7

Yeah its a bit of a worry that you can manipulate the price with 3500 shares.. no one wants to buy this stock, why would you? The nearest buyer is at 4.1c now. What has happened in 2 months since the 'change in strategy' announcement? Have they met with the FDA? What's the timeline for approvals of the pharmaceutical route? what was the FDA guidance? have they spoken to potential partners? is anyone interested in partnering? All I have, as per usual with this company, is questions, lots of questions...